Revenue: As of FY2025 Q3, the actual value is USD 59.38 M.

EPS: As of FY2025 Q3, the actual value is USD 0.02.

EBIT: As of FY2025 Q3, the actual value is USD 2.198 M.

Segment Revenue

• Total Revenue: $59.4 million for Q3 2025, a 25% increase YoY, driven by a 42% increase in Payor revenue, partially offset by a 23% decline in Consumer revenue.
• Payor Revenue: $45.5 million for Q3 2025, a 42.1% increase YoY.
• DTE Revenue: $9.3 million for Q3 2025, a 1.2% decrease YoY.
• Consumer Revenue: $4.6 million for Q3 2025, a 23.1% decrease YoY.

Operational Metrics

• Net Income: $3.3 million for Q3 2025, a 73% increase YoY.
• Adjusted EBITDA: $5.0 million for Q3 2025, an improvement from $2.4 million in Q3 2024. Adjusted EBITDA grew by 111% YoY in Q3 2025, with a Last Twelve Months (LTM) Adjusted EBITDA of approximately $11.9 million compared to approximately $4.0 million a year ago.
• Total Costs and Operating Expenses: $57.2 million for Q3 2025, a 21% increase YoY.

Cash Flow

• Cash, Cash Equivalents, and Restricted Cash: $43.7 million at the end of Q3 2025. The company reported a strong balance sheet with $0 debt and approximately $96 million in cash, cash equivalents, and restricted cash, including marketable securities, available for growth investments.

Unique Metrics

• Number of Completed Payor Sessions: 432.2 thousand for Q3 2025, a 37% increase YoY.
• Number of Unique Active Payor Members: 120.6 thousand for Q3 2025, a 29% increase YoY.

Outlook / Guidance

• Revenue Guidance: Updated to be in the range of $226 million to $230 million for 2025. The company provided financial guidance for 2025, expecting revenue between $220 million to $235 million, representing a 17% to 25% YoY increase.
• Adjusted EBITDA Guidance: Updated to be in the range of $14 million to $16 million for 2025. Adjusted EBITDA is projected to be between $14 million to $20 million, reflecting a 101% to 187% YoY growth.